[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_102":103},"en-item",{"_9":10,"_10":11},"kind","item",{"_12":13,"_14":15,"_16":17,"_18":19,"_20":21,"_22":23,"_24":25,"_26":27,"_28":29,"_30":31,"_32":31,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":46,"_47":-5,"_48":49,"_50":-5,"_51":-5,"_52":53,"_54":55,"_56":57,"_58":42,"_59":42,"_60":61,"_62":42,"_63":64},"id","su95wzr4w7cqktw14yczbk4y1","revision",2,"title","Alignment Healthcare 预期2027年加州HMO计划星级评分降至3.5","originalTitle","Alignment Healthcare, Inc. (0001832466) (Filer)","summary","Alignment Healthcare 预期其加州HMO健康计划（H3815）在2027年将获得3.5星评级，较2026年的4.0星有所下降。公司表示将采取措施提升评分，并计划挑战CMS的计算方法。该评级变化可能影响2028年的质量奖金支付，但不会影响2026或2027财年的收入。","reason","Alignment Healthcare 预期其加州HMO计划2027年星级评分将从4.0降至3.5，可能影响2028年的质量奖金支付。","source",{"_12":93,"_94":95,"_9":96,"_97":42,"_98":99,"_100":101},"links",{"_90":91,"_78":92},"publishedAt","2026-10-08T21:13:20.000Z","discoveredAt","2026-10-08T21:24:30.436Z","timelineAt","category","ai-products","tags",[84,85,86,87,88,89],"stockSymbols",[83],"score",65,"selected",true,"channel","news","story",{"_73":74,"_16":75},"x","readingMode","full","author","language","body",{"_64":77,"_78":-5,"_79":80,"_81":82},"outline",[],"relatedStories",[76],"indexable","markdownAvailable","group",{"_65":66,"_45":67,"_68":69,"_70":71,"_72":71},"hasTranslation","bodyLanguage","zh","factId","fwkehutIYRmk",{"_73":74,"_16":75},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","55097f7a-6dd8-45ca-b151-ecb8263b135b","Alignment Healthcare 评级下调预期",{"_73":74,"_16":75},"

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 8, 2026

_______________________________

ALIGNMENT HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

_______________________________


Delaware	001-40295	46-5596242
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

1100 W. Town and Country Road, Suite 1600

Orange, California 92868

(Address of Principal Executive Offices) (Zip Code)

(844) 310-2247

(Registrant's telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	ALHC	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 7.01 Regulation FD Disclosure.

2027 Health Plan Stars Ratings

On October 8, 2026, the Centers for Medicare & Medicaid Services (“CMS”) released its 2027 Star Ratings for Medicare Advantage (“Medicare Part C”) and Medicare Part D prescription drug plans. Based on the newly released Star Ratings, Alignment Healthcare, Inc. (the “Company”) expects that its California HMO health plan contract (H3815) will have a 3.5-Star Rating for rating year 2027. H3815, which had a 4.0-Star Rating for rating year 2026, serves approximately 75% of the Company’s health plan membership. Alignment expects to retain a 4.0-Star or higher rating in each of its six other eligible plans, including three plans that achieved a 4.5-Star Rating.

Based on the Company's review of the data provided by CMS, the decline in Stars performance was driven primarily by higher industry cut points and a decline in certain triple-weighted measures across Health Outcomes Survey (HOS) and Part D.

此外，CMS在绩效周期结束后追溯性地取消与卓越健康结果指数（也曾被称为健康公平指数）相关的奖金计算，这降低了公司为符合CMS之前实施目标而做出的投资影响。

公司已并将继续实施全公司范围的举措，包括提高会员和提供者的参与度、扩大护理差距闭合计划并提供额外的质量监督。公司认为这些措施将加强我们的业务，并使H3815在未来的评级年度中恢复至少4.0星的评级。

公司打算提出针对某些CMS计算的行政上诉，并预计将在某些星级评分指标和方法上提起诉讼，公司认为这些指标和方法与适用法律和CMS的法定权限不一致。

2027年度的星级评分结果预计不会影响公司2026年或2027财年的收入。2027年度星级评分表现的变化将影响公司2028财年的质量奖金支付。公司预计其与提供者的风险共担安排将抵消部分影响。此外，公司正在积极寻求所有选项以减轻2028年的潜在财务影响。最后，由于约50%的Alignment会员在过去两年内加入公司，公司预计其现有会员中的嵌入式收益增长将支持其未来几年的利润率。

谨慎声明

本8-K格式的当前报告包含根据《1933年证券法》第27A条、《1934年证券交易法》第21E条以及《1995年私人证券诉讼改革法案》的含义所定义的前瞻性声明。前瞻性声明受风险和不确定性影响，并基于可能不准确的假设，这可能导致实际结果与前瞻性声明所预期或暗示的结果有重大差异。实际结果可能与预测结果有重大差异，已报告的结果不应被视为未来表现的指标。可能导致公司实际结果和财务状况与前瞻性声明中所指示的结果有重大差异的重要风险和不确定性包括但不限于以下内容：公司吸引新会员和进入新市场的能力，包括对某些政府批准的需要；其在五星级质量评级系统中实现或保持高评级的能力；在未来评级年份将H3815恢复至4.0星级评级的能力；相关行政上诉和诉讼的成功以及相关缓解措施的成功；实现盈利增长以支持公司利润率轨迹的能力；与为会员提供服务的医疗提供者建立和维持满意关系的能力；作为政府承包商所涉及的风险；适用于其商业模式的法律和法规的变化；与其债务相关的风险；市场或行业状况的变化以及对其技术和服务的接受度；诉讼结果或安全事件的结果；以及合格人员短缺及其劳动力成本增加的影响。有关可能影响公司实际结果的风险因素的详细讨论，请参阅其截至2025年12月31日的年度报告10-K表格中确定的风险因素，以及其向证券交易委员会提交的其他定期报告。本8-K格式的当前报告中提供的所有信息均为本日的日期，除非法律要求，公司不承担更新或修订此信息的义务。

本8-K格式的当前报告第7.01项中的信息不得视为根据《1934年证券交易法》第18条（“证券交易法”）“提交”的信息，也不受该条的任何责任约束，也不应视为在任何根据《1933年证券法》或《证券交易法》提交的文件中通过引用而纳入。

除非在该文件中明确通过具体引用规定，否则此类信息和附录不得视为通过引用纳入任何根据《1933年证券法》或《证券交易法》提交的文件中。

签名

根据《1934年证券交易法》的要求，注册人已 duly 促使本报告由此处 duly 授权的人员代表其签署。


	Alignment Healthcare, Inc.


日期：2026年10月8日	由：	/s/ Christopher Joyce
		Christopher Joyce
		首席法律与行政官

","original","zhKind","translation","complete",false,"ALHC","公司与财报","宏观与美联储","行业与主题","政策与监管","观点与解读","其他","aihot","/items/su95wzr4w7cqktw14yczbk4y1","https://www.sec.gov/Archives/edgar/data/1832466/000162828026065470/0001628280-26-065470-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1791763200&sig=95a77c187c5dca32","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1791763200&sig=3a0fa885471986b2 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1791763200&sig=31c65723824c6538 96w","changelogVersion","2026-10-01T08:00"]